You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 146 No. 9, September 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Elimination Kinetics of Maternally Derived Thyrotropin Receptor–Blocking Antibodies in a Newborn With Significant Thyrotropin Elevation

Anton-Lewis Usala, MD; Isaiah Wexler, MD; Amy Posch; Manjula K. Gupta, PhD

Am J Dis Child. 1992;146(9):1074-1077.


Abstract

• Objective.
—To determine the course of maternally derived elevations in thyrotropin-binding inhibitory immunoglobulins in a neonate.

Design.
—Case report.

Setting.
—University pediatric endocrinology clinic and endocrine immunology laboratory in Ohio.

Participants.
—An infant with elevated thyrotropin levels but near-normal total thyroxine levels, and her mother.

Interventions.
—None.

Measurements/Main Results.
—Thyroid hormone, thyrotropin, and thyrotropin-blocking immunoglobulin concentrations were serially measured in a woman and her infant, who was found to have elevated thyrotropin levels (234 mU/L) and borderline low thyroxine levels (95 nmol/L). As infant thyroxine concentrations remained normal (125 to 145 nmol/L), no thyroxine supplementation was given. Thyrotropin levels decreased concomitantly with thyrotropin-blocking inhibitory immunoglobulin levels, and normalized by day 56 of life. The apparent elimination half-life of thyrotropin-blocking immunoglobulins was 7.5 days.

Conclusions.
—The observed parallel elimination kinetics suggest that the thyrotropin receptor antibody acts as a thyrotropin antagonist, resulting in compensatory thyrotropin elevations. The duration of such elevations may be predicted on the basis of such elimination.

(AJDC. 1992;146:1074-1077)



Author Affiliations

From the Division of Pediatric Endocrinology and Metabolism, Rainbow Babies and Children's Hospital, Cleveland, Ohio (Drs Usala and Wexler); the Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland (Drs Usala and Wexler); and the Department of Immunopathology, The Cleveland Clinic Foundation (Ms Posch and Dr Gupta). Dr Usala is currently with the Section of Pediatric Endocrinology, East Carolina University School of Medicine, Greenville, NC.


Footnotes

Accepted for publication May 26, 1992.

Presented in part at the 72nd Endocrine Society Meeting, Atlanta, Ga, June 20, 1990.

Reprint requests to Section of Pediatric Endocrinology, East Carolina University School of Medicine, Brody Building 3E133, Greenville, NC 27858-4354 (Dr Usala).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.